First patient treated with CLS prostate cancer therapy system

By staff writers

April 22, 2022 -- Clinical Laserthermia Systems (CLS) Americas said the first patient has been treated in a prostate cancer trial using the company's Tranberg thermal therapy system.

The 20-patient, phase I clinical study combines the system with the Focalyx Fusion medical device for treatment planning, image fusion, and real-time image guidance via MRI during focal laser ablation treatment for prostate cancer.

The study is being led by the Florida-based Urological Research Network.

Copyright © 2022

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking